Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Elevating Care for Patients With Severe Renal Disease in AAV
Silke R. Brix, MD, MRCP, SCPR
Andreas Kronbichler, MD
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
Alexander T. Cohen, MD, MBBS
Optimizing AAV Outcomes: Maintenance Therapies
Bernhard Hellmich, MD
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Valeria Caso, MD, PhD
Don't Miss It! Rapid & Accurate AAV Diagnosis
Patient Case Study: Obesity and VTE
Renato D. Lopes, MD, MHS, PhD
Patient Case Study: Cancer-Associated Thrombosis
Patient Case Study: Obesity
Patient Case Study: Elderly
Trade off: Ischemic/Thrombotic vs Bleeding
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
Managing Patients With AAV in the Rheumatology Clinic
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.